This page houses WEB-RADR outputs.

Work Package 1: Governance and policy

Workshop 10 December 2014 – agenda and report

Workshop 18 October 2016 – agenda and report

Publication – Social Media Monitoring and Adverse Drug Reaction Reporting in Pharmacovigilance: An Overview of the Regulatory Landscape

Coming soon: Report on the assessment of personal data protection legislation requirements (D1.3.1)

Coming soon: Ethical and data privacy recommendations in social media research and pharmacovigilance – a literature review (D1.3.2)

Coming soon: Framework for use of social media in pharmacovigilance (D1.4.1) 01 Policy on the use of mobile devices for easier, faster and more user-friendly reporting by patients, consumers and healthcare professionals and access to collected reports for signal detection purposes in the context of pharmacovigilance

Coming soon: Framework for use of social media in pharmacovigilance (D1.4.1) 02 Recommendations on the use of mobile devices for easier, faster and more user-friendly reporting by patients, consumers and healthcare professionals and access to collected reports for signal detection purposes in the context of pharmacovigilance

Coming soon: Framework for use of social media in pharmacovigilance (D1.4.2)

Coming soon: Framework for ethical considerations for the use of social media in pharmacovigilance (D1.5)

Work Package 2A: Social media

Collaborative User Interface Images

WEB-RADR Products for Social Media Monitoring

Report on Data Collection June 2015

Report on Data Collection November 2016

Report on Data Collection September 2017

Report on Language Classifiers September 2017

 

Work Package 2B: Analytics

Technical report WP2B ADE detection – Benchmark analysis of baseline methods for ADR detection in social media

Technical report describing implementation and evaluation of AE recognition in social media (D2B.1)

Technical report describing implementation and evaluation of record linkage in social media (D2B.2)

Study Summary Analytics – Record Linkage

Technical report describing implementation and evaluation of safety signal detection in social media (D2B.3)

IMI WEB-RADR Workshop Topic 6: Analysis of social media comments for pharmacovigilance purposes

WEBRADR WP2B Study Summary Analytics – Signal Detection

WEBRADR WP2B – Analytics – Signal detection Workstream

WEB-RADR WP2B Social Media Data Analysis Manual

Poster: Performance of Disproportionality Analysis for Statistical Signal Detection in Social Media Data

Search term reduction analysis on Reddit data – Epidemico and Uppsala Monitoring Centre joint subproject in WEB-RADR WP2b

Poster: Medication name entity recognition in Tweets using global dictionary lookup and word sense disambiguation

Poster: Improving the yield of relevant data for pharmacovigilance analysis by reducing search term complexity

 

Work Package 3A: Mobile reporting platform

Reporting and alerting mobile application – requirements specifications 

WEB-RADR App Images

WEB-RADR WP3A Mobile app available for Second and Third Member State users

Report on Electronic Health Record Connectivity (D3A.7)

Report on changes required to the WEB RADR app to move from E2B (R2) to (R3) (D3A.8)

Instruction manual and online portal for adoption by additional Member State – App Overview Documentation (D3A.8)

Instruction manual and online portal for adoption by additional Member State – App Design Documentation (D3A.8)

Instruction manual and online portal for adoption by additional Member State – Portal Configuration Documentation (D3A.8)

Instruction manual and online portal for adoption by additional Member State – Test Scenario Documentation (D3A.8_web)

Instruction manual and online portal for adoption by additional Member State – Appendix Documentation (D3A.8)

Yellow Card app video

Yellow Card app launch, Minister George Freeman

Publication: WEB-RADR Goes Sub-Sahara, Uppsala reports

Publication: Drug-name look-up in mobile apps made easier, Uppsala reports

 

Work Package 3B: User based evaluation

Study 1. Qualitative evaluation of a mobile app to assess side effects

Study 2. Quantitative evaluation of a mobile app on two-way risk communication

Study 3. Assessment of experiences of WEB-RADR app users, results user experiences evaluation

Study 4. Assessment of experiences of Web-RADR app users

Pilot project patient-friendly terms

Publication: Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study

Publication: Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients

Publication: Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study

Poster: Barriers and facilitators for a mobile app to report Adverse Drug Reactions & receive information about drugs A qualitative, multinational study

 

Work Package 4: Scientific Impact Evaluation

Estimating the Pertinent Information Present in Social Media and Assessing where it can Add Value to Pharmacovigilance (D4.6)

User instruction clinical quality tool (D4.3)

Clinical quality tool calculator (D4.3)

Characterization of spontaneous reports received through the app (D4.2) and Identification of the rate of duplication of reports in apps compared to conventional reporting methods (D4.5)

Report on the identification of safety signals through mining of social media and comparison with the timelines of how quickly they were detected through regular reporting methods (D4.7)

Signal detection using pharmacovigilance data from different sources (D4.9)

Publication: Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study

Publication: Social Media and Pharmacovigilance: A Review of the Opportunities and Challenges

Poster: Characteristics and Quality of Spontaneous ADR Reports Submitted via the WEB-RADR App

 

Work Package 5: Project management and communication

Publication: Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social media

Publication: Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR

Publication: IMI Newsletter, 57th Edition – May 2016

Poster: What is WEB-RADR?

Interview: IMI interview with WEB-RADR project coordinators

General Assembly, 21 April 2016

 

Stakeholder Event, 7 September 2017